论文部分内容阅读
目的:探讨毛细支气管炎采取利巴韦林不同给药方式治疗的疗效。方法:选取2014年5月至2015年5月罗定市中医院接收的毛细支管炎120例患儿,根据给药方式不同分为静脉滴注组、压缩雾化吸入组、超声雾化吸入组,各40例,均给予利巴韦林治疗,比较3组患儿的疗效及相关观察指标。结果:两种雾化方式治疗小儿呼吸道病毒感染的疗效、症状改善、血气指标改善均显著优于静脉用药组,差异具有统计学意义(P<0.05),压缩雾化组上述指标更优于超声雾化组,差异具有统计学意义(P<0.05)。结论:小儿毛细支气管炎采取利巴韦林雾化吸入治疗更有利于发挥作用,改善临床症状,其中压缩雾化较超声雾化效果更佳。
Objective: To investigate the efficacy of different routes of administration of ribavirin for bronchiolitis. Methods: From May 2014 to May 2015, 120 children with capillaries received by Luoding Hospital of Traditional Chinese Medicine were divided into three groups: intravenous drip group, compressed atomizing inhalation group and ultrasonic atomizing inhalation group , Each 40 cases, were given ribavirin treatment, the efficacy of the three groups were compared with the relevant observation indicators. Results: The curative effect, symptom improvement and improvement of blood gas index of two kinds of atomization methods in children with respiratory virus infection were significantly better than that of intravenous drug group (P <0.05). The above indexes in compression atomization group were better than those in ultrasound group At atomization group, the difference was statistically significant (P <0.05). Conclusion: Infantile bronchiolitis with ribavirin inhalation therapy is more conducive to play a role in improving clinical symptoms, of which compressed atomization is better than ultrasonic atomization.